Genomic Health, Inc. Announces Ten Studies Covering Breast, Colon and Prostate Cancers Accepted for Presentation at the American Society of Clinical Oncology Annual Meeting
5/21/2013 7:17:49 AM
More...
|
Genomic Health, Inc. Announces Medicare Expanded Coverage Policy for Oncotype DX® Breast Cancer Test to Include Ductal Carcinoma in Situ (DCIS) Diagnosis
5/13/2013 9:47:18 AM
More...
|
Genomic Health, Inc. Announces Availability of Oncotype DX® Prostate Cancer Test With Potential to Triple the Number of Patients Who Can Confidently Choose Active Surveillance and Avoid Side Effects of Invasive Treatments
5/8/2013 10:52:49 AM
More...
|
Genomic Health, Inc.'s Genetic Test Helps Identify Aggressive Prostate Cancer
5/8/2013 8:20:45 AM
More...
|
Genomic Health, Inc. to Present at Bank of America (BAC) Merrill Lynch Health Care Conference
5/8/2013 6:56:24 AM
More...
|
Genomic Health, Inc. and ECOG-ACRIN Cancer Research Group Announce Publication of Positive DCIS Validation Study in the Journal of the National Cancer Institute
5/3/2013 9:31:18 AM
More...
|
Genomic Health, Inc. Announces First Quarter 2013 Financial Results and Business Progress
5/3/2013 6:56:11 AM
More...
|
Genomic Health, Inc. Announces Investor Webcast and Conference Call to Review Positive Clinical Validation and Development of the Oncotype DX® Prostate Cancer Test on Wednesday, May 8, 2013
5/2/2013 9:17:48 AM
More...
|
Genomic Health, Inc. to Announce First Quarter 2013 Financial Results and Host Conference Call on Thursday, May 2, 2013
4/25/2013 7:45:57 AM
More...
|
Genomic Health, Inc. Announces Publication of Second Positive Validation of Oncotype DX Colon Cancer Test Confirming Its Value Beyond Conventional Markers
4/17/2013 9:43:20 AM
More...
|
|